Johnson & Johnson (LON:0R34)
London
· Delayed Price · Currency is GBP · Price in USD 155.49
-0.18 (-0.12%)
At close: Jul 2, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2012 - 2019 |
Consumer Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicine | 56.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicine Growth | 4.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedTech | 31.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedTech Growth | 4.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2012 - 2019 |
Other | 271.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Health Capital Expenditures | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Health Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicine Capital Expenditures | 1.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicine Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedTech Capital Expenditures | 2.44B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedTech Capital Expenditures Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 271.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 271.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2012 - 2019 |
United States | 50.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 7.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 20.21B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 0.88% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Hemisphere ex-US | 4.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Western Hemisphere ex-US Growth | 0.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific, Africa | 13.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific, Africa Growth | -1.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | Jan '21 Jan 3, 2021 | 2012 - 2019 |
Other | -5.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -352.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -5.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -352.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Health Income Before Tax | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consumer Health Income Before Tax Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicine Income Before Tax | 18.92B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Innovative Medicine Income Before Tax Growth | 4.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedTech Income Before Tax | 3.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MedTech Income Before Tax Growth | -6.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | -5.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -352.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales % Change due to Transactions | 5.90 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales % Change due to Transactions Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales % Change due to Price | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales % Change due to Price Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales % Change due to Currency | -1.60 |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Sales % Change due to Currency Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|